Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (171)
- Scheduling (national classification system) (58)
- Manufacturing (28)
- Advertising (22)
- Unique Device Identification (UDI) hub (21)
- Safety monitoring and information (18)
- Compliance and enforcement (14)
- Clinical trials (10)
- Vaping hub (9)
- Legislation (8)
- Medicinal cannabis hub (5)
- Shortages and supply disruptions (3)
- Breast implant hub (2)
- Cosmetics (1)
- Import and export (1)
- Labelling and packaging (1)
Search
415 result(s) found, displaying 126 to 150
-
-
-
PresentationsThis webinar will explain labelling requirements for finished MCP in detail.
-
-
PresentationsThis webinar will guide you through the process of charging for regulatory activities, the medicinal cannabis funding model and the fees and charges structure and amounts proposed to commence on 1 July 2023.
-
WebinarsThe final webinar in this series will explore the impact changes to the EU MDR will have on consent to supply and market notifications.
-
PresentationsThe final webinar in this series will explore the impact changes to the EU MDR will have on consent to supply and market notifications.
-
WebinarsThis webinar will focus on how the changes under the EU MDR will affect manufacturer evidence and variations to the ARTG.
-
WebinarsChanges to the formatting and structure of the Poisons Standard will come into effect from 1 February 2023
-
PresentationsPresentation on the new formatting and structure of the Poisons Standard
-
PresentationsThis is the second in a series of three educational webinars outlining what regulatory actions are required as a result of changes under the EU MDR, with a focus on manufacturer evidence and variations to the ARTG.
-
WebinarsThis webinar will outline what regulatory actions are required as a result of changes under the EU MDR, and how the TGA will streamline the transition.
-
PresentationsThis is the first in a series of three educational webinars outlining what regulatory actions are required as a result of changes under the EU MDR.
-
Committee meetingsTherapeutic Goods Advertising Consultative Committee
-
-
WebinarsThe purpose of this webinar was to help sponsors understand how to use the Listed Medicines Evidence Guidelines to compile a robust evidence package that supports the efficacy of their listed medicine.
-
Committee meetingsThe 35th meeting of the Advisory Committee on Chemicals Scheduling (ACCS #35), November 2022.
-
Committee meetingsThe 40th meeting of the Advisory Committee on Medicines Scheduling (ACMS #40), November 2022.
-
Committee meetingsAdvisory Committee on Biologicals (ACB) meeting
-
Committee meetingsThe 32nd joint meeting of the Advisory Committee on Medicines Scheduling and Chemicals Scheduling (Joint ACMS-ACCS #32), November 2022.
-
Committee meetingsAdvisory Committee on Complementary Medicines (ACCM) meeting
-
PresentationsPresentation at the RACI Pharmaceutical Science Group (NSW) Seminar/Webinar, information for manufacturers of medicinal products on Computerised Systems - establishing and maintaining data integrity
-
WebinarsA webinar covering how to view and respond to notifications in the Consent for Non-compliance Dashboard
-
PresentationsThis webinar will cover the process of submitting evidence of compliance with the EPs for devices in a consent application in a live demonstration.
-
PresentationsThis webinar will guide you through the process of applying for consent to import, supply or export a medical device non-compliant with the Essential Principles.